Volume 6, Number 1 (1-2017)                   IEJM 2017, 6(1): 37-43 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghareaghaji Zare A, Khodayiani E, Saniee S, Talghini S. Expression of cyclooxygenase-2 in melanocytic skin lesions by immunohistochemistry. IEJM. 2017; 6 (1) :37-43
URL: http://iejm.hums.ac.ir/article-1-103-en.html

Abstract:   (263 Views)

Introduction: cyclooxygenase-2 (COX-2) is involved in pathogenesis of various tumors and possibly malignant skin tumors including malignant melanoma; however, there is not enough information about COX-2 expression in benign melanocytic lesions. In the present study we compared the expression levels of COX-2 in malignant melanoma and benign melanocytic lesions. Method: In this analytical study, 42 malignant melanoma from all 4 subtypes and 38 benign melanocytic lesions including dysplastic nevus, Spitz nevus and atypical nevus were evaluated for COX-2 expression using immunohistochemistry staining and intensity of cell staining (quantitatively and qualitatively). Results: Malignant melanoma compared to benign melanocytic lesions had significantly higher levels of staining (p<0.001), and much more intense coloration (p<0.001) and higher overall staining score (p<0.001). Regarding the COX2 staining between malignant melanoma subtypes, all four subtypes mostly had staining intensity over 60%. Also in terms of quality, the most intense staining was in the ALM ,and LM and NM had moderate staining intensity. With increasing depth of involvement, Cox2 staining increases. Intensity of cell staining was also higher in cases with tumor depth of 2-4 mm. Conclusion: The results indicates the effectiveness of COX2 in differentiating between malignant melanoma and benign melanocytic lesions. COX2 expression correlated with the depth of invasion. Although COX2 alone can not be used to differentiate melanoma from benign lesions, it can be helpful in combination with other methods,in determining the prognosis and future targeted therapies.

Full-Text [PDF 738 kb]   (511 Downloads)    
Type of Study: Original Article | Subject: General
Received: 2016/09/6 | Accepted: 2016/09/6 | Published: 2016/09/6

Add your comments about this article : Your username or email:
Write the security code in the box

© 2015 All Rights Reserved | International Electronic Journal of Medicine

Designed & Developed by : Yektaweb